<html>
<head>
<meta content="text/html; charset=ISO-8859-1"
http-equiv="Content-Type">
</head>
<body bgcolor="#FFFFFF" text="#000000">
<span lang="FR-CH">Can you please take me off this mailing list ?
</span>thanks <br>
<br>
Isabelle<br>
<br>
Le 11/03/13 14:26, Cassetti, Cristina (NIH/NIAID) [E] a écrit :
<blockquote
cite="mid:39A8E68A7613ED4E8DCE3AC85F58BE5F4F34AE@MLBXV01.nih.gov"
type="cite">
<meta http-equiv="Content-Type" content="text/html;
charset=ISO-8859-1">
<meta name="Generator" content="Microsoft Word 14 (filtered
medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:Wingdings;
panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:Wingdings;
panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
{font-family:Consolas;
panose-1:2 11 6 9 2 2 4 3 2 4;}
@font-face
{font-family:Verdana;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
pre
{mso-style-priority:99;
mso-style-link:"HTML Preformatted Char";
margin:0in;
margin-bottom:.0001pt;
font-size:10.0pt;
font-family:"Courier New";}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
{mso-style-priority:99;
mso-style-link:"Balloon Text Char";
margin:0in;
margin-bottom:.0001pt;
font-size:8.0pt;
font-family:"Tahoma","sans-serif";}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
{mso-style-priority:34;
margin-top:0in;
margin-right:0in;
margin-bottom:0in;
margin-left:.5in;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
span.HTMLPreformattedChar
{mso-style-name:"HTML Preformatted Char";
mso-style-priority:99;
mso-style-link:"HTML Preformatted";
font-family:Consolas;}
span.BalloonTextChar
{mso-style-name:"Balloon Text Char";
mso-style-priority:99;
mso-style-link:"Balloon Text";
font-family:"Tahoma","sans-serif";}
span.EmailStyle22
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle23
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle24
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:70.85pt 85.05pt 70.85pt 85.05pt;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:1826899768;
mso-list-type:hybrid;
mso-list-template-ids:1040480274 7743204 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l0:level1
{mso-level-start-at:0;
mso-level-number-format:bullet;
mso-level-text:-;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Calibri","sans-serif";
mso-fareast-font-family:Calibri;}
@list l0:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Courier New";}
@list l0:level3
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Wingdings;}
@list l0:level4
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l0:level5
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Courier New";}
@list l0:level6
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Wingdings;}
@list l0:level7
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l0:level8
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Courier New";}
@list l0:level9
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Wingdings;}
ol
{margin-bottom:0in;}
ul
{margin-bottom:0in;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
<div class="WordSection1">
<p class="MsoNormal"><span lang="FR-CH">Can you please take me
off this mailing list ?
<o:p></o:p></span></p>
<p class="MsoNormal"><span lang="FR-CH">Thank you,<o:p></o:p></span></p>
<p class="MsoNormal"><span lang="FR-CH">Cristina</span><span
style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D"><o:p></o:p></span></p>
<p class="MsoNormal"><span
style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D"><o:p> </o:p></span></p>
<div>
<div style="border:none;border-top:solid #B5C4DF
1.0pt;padding:3.0pt 0in 0in 0in">
<p class="MsoNormal"><b><span
style="font-size:10.0pt;font-family:"Tahoma","sans-serif"">From:</span></b><span
style="font-size:10.0pt;font-family:"Tahoma","sans-serif"">
Farrokh Modabber [<a class="moz-txt-link-freetext" href="mailto:fmodabber@dndi.org">mailto:fmodabber@dndi.org</a>]
<br>
<b>Sent:</b> Monday, February 11, 2013 7:38 PM<br>
<b>To:</b> 'Carlos Costa'; 'Leish-L'<br>
<b>Subject:</b> [Leish-l] What are the most polemic
issues in leishmaniasis?<o:p></o:p></span></p>
</div>
</div>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><span
style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D">Dear
Carlos,<o:p></o:p></span></p>
<p class="MsoNormal"><span
style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D">I
think
<i>Leishmania</i> classification should be updated. I have
problem with identification of
<i>Leishmania</i> isolates based on non-biological markers.
The ones used, i.e. genetic markers (not associated with
known biological activity), iso-enzymes electrophoresis (all
the isoenzymes have the same biological activity and changes
somewhere in the enzyme molecule cause different
electrophoretic migration). Now that we know conjugation
(transfer of genetic material from one to another
<i>Leishmania</i>) occur, and with the whole genome
sequencing available, isn’t it time to look for biological
markers? The tools used, have helped us establish the
evolutionary trees but do not help us in knowing what kind
of disease each isolate will produce, their vector
specificity, etc. I realize that disease outcome also
depends on host response, but still some better markers may
be identified.<o:p></o:p></span></p>
<p class="MsoNormal"><span
style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D">What
do you think?<o:p></o:p></span></p>
<p class="MsoNormal"><span
style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D">All
the best,<o:p></o:p></span></p>
<p class="MsoNormal"><span
style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D">Farrokh
<o:p></o:p></span></p>
<p class="MsoNormal"><span
style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D"><o:p> </o:p></span></p>
<div>
<div style="border:none;border-top:solid #B5C4DF
1.0pt;padding:3.0pt 0in 0in 0in">
<p class="MsoNormal"><b><span
style="font-size:10.0pt;font-family:"Tahoma","sans-serif"">From:</span></b><span
style="font-size:10.0pt;font-family:"Tahoma","sans-serif"">
<a moz-do-not-send="true"
href="mailto:leish-l-bounces@lineu.icb.usp.br">leish-l-bounces@lineu.icb.usp.br</a>
[<a moz-do-not-send="true"
href="mailto:leish-l-bounces@lineu.icb.usp.br">mailto:leish-l-bounces@lineu.icb.usp.br</a>]
<b>On Behalf Of </b>Israel Cruz Mata<br>
<b>Sent:</b> lundi 11 février 2013 09:46<br>
<b>To:</b> 'Carlos Costa'; 'Leish-L'<br>
<b>Subject:</b> Re: [Leish-l] hot spots<o:p></o:p></span></p>
</div>
</div>
<p class="MsoNormal"><span lang="FR-CH"><o:p> </o:p></span></p>
<p class="MsoNormal"><span
style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D"
lang="ES">Hi Carlos,<o:p></o:p></span></p>
<p class="MsoNormal"><span
style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D"
lang="ES"><o:p> </o:p></span></p>
<p class="MsoNormal"><span
style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D">I´m
curious about these:<o:p></o:p></span></p>
<p class="MsoNormal"><span
style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoListParagraph"
style="text-indent:-.25in;mso-list:l0 level1 lfo2"><!--[if !supportLists]--><span
style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D"><span
style="mso-list:Ignore">-<span style="font:7.0pt
"Times New Roman"">
</span></span></span><!--[endif]--><span
style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D">“Leishmania
siamensis”: causing dermal and visceral human leishmaniasis
in Thailand, cutaneous equine and bovine leishmaniasis in
central Europe, and equine cutaneous leishmanaisis in USA.<o:p></o:p></span></p>
<p class="MsoListParagraph"><span
style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D">Is
it really the same parasite in all cases, it is a new
Leishmania specie emerging worldwide?<o:p></o:p></span></p>
<p class="MsoListParagraph"><span
style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoListParagraph"
style="text-indent:-.25in;mso-list:l0 level1 lfo2"><!--[if !supportLists]--><span
style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D"><span
style="mso-list:Ignore">-<span style="font:7.0pt
"Times New Roman"">
</span></span></span><!--[endif]--><span
style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D">Leishmania
in Macropods and its transmission by midges
(Ceratopogonidae), not sandflies.<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left:.25in"><span
style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoListParagraph"
style="text-indent:-.25in;mso-list:l0 level1 lfo2"><!--[if !supportLists]--><span
style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D"><span
style="mso-list:Ignore">-<span style="font:7.0pt
"Times New Roman"">
</span></span></span><!--[endif]--><span
style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D">Control
strategies for ZVL in South America: alternatives for dog
culling.<o:p></o:p></span></p>
<p class="MsoNormal"><span
style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span
style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D">All
the best,<o:p></o:p></span></p>
<p class="MsoNormal"><span
style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span
style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D">Isra<o:p></o:p></span></p>
<p class="MsoNormal"><span
style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><b><span
style="font-size:10.0pt;font-family:"Tahoma","sans-serif""
lang="ES">De:</span></b><span
style="font-size:10.0pt;font-family:"Tahoma","sans-serif""
lang="ES">
<a moz-do-not-send="true"
href="mailto:leish-l-bounces@lineu.icb.usp.br">leish-l-bounces@lineu.icb.usp.br</a>
[<a moz-do-not-send="true"
href="mailto:leish-l-bounces@lineu.icb.usp.br">mailto:leish-l-bounces@lineu.icb.usp.br</a>]
<b>En nombre de </b>Carlos Costa<br>
<b>Enviado el:</b> jueves, 07 de febrero de 2013 20:39<br>
<b>Para:</b> Leish-L<br>
<b>Asunto:</b> [Leish-l] hot spots<o:p></o:p></span></p>
<p class="MsoNormal"><span lang="ES"><o:p> </o:p></span></p>
<div>
<p class="MsoNormal"><span
style="font-family:"Verdana","sans-serif";color:black"
lang="ES">What are the most polemic issues in
leishmaniasis?<br clear="all">
</span><span lang="ES"><o:p></o:p></span></p>
<div>
<p class="MsoNormal"><span lang="ES"><o:p> </o:p></span></p>
</div>
<p class="MsoNormal"><span lang="ES">-- <o:p></o:p></span></p>
<p class="MsoNormal"><span
style="font-family:"Verdana","sans-serif""
lang="ES">Carlos H. N. Costa, MD, DSc.</span><span
lang="ES"><o:p></o:p></span></p>
<p class="MsoNormal"><span
style="font-family:"Verdana","sans-serif""
lang="ES">Sociedade Brasileira de Medicina Tropical </span><span
lang="ES"><o:p></o:p></span></p>
<p class="MsoNormal"><span
style="font-family:"Verdana","sans-serif""
lang="ES">(Brazilian Society of Tropical Medicine)</span><span
lang="ES"><o:p></o:p></span></p>
<p class="MsoNormal"><span
style="font-family:"Verdana","sans-serif""
lang="ES">President</span><span lang="ES"><o:p></o:p></span></p>
<p class="MsoNormal"><span lang="ES"><o:p> </o:p></span></p>
<p class="MsoNormal"><span
style="font-family:"Verdana","sans-serif""
lang="ES">Universidade Federal do Piauí</span><span
lang="ES"><o:p></o:p></span></p>
<div>
<p class="MsoNormal"><span
style="font-family:"Verdana","sans-serif""
lang="ES">Instituto de Doenças Tropicais Natan Portella</span><span
lang="ES"><o:p></o:p></span></p>
<p class="MsoNormal"><span
style="font-family:"Verdana","sans-serif""
lang="ES">Rua Artur de Vasconcelos 151-Sul</span><span
lang="ES"><o:p></o:p></span></p>
<div>
<p class="MsoNormal"><span
style="font-family:"Verdana","sans-serif""
lang="ES">64001-450 Teresina-PI</span><span lang="ES"><o:p></o:p></span></p>
<p class="MsoNormal"><span
style="font-family:"Verdana","sans-serif""
lang="ES">Brazil<o:p></o:p></span></p>
<p class="MsoNormal"><span
style="font-family:"Verdana","sans-serif""
lang="ES">Telephones: +55 86 3222-4377 (W), <o:p></o:p></span></p>
<p class="MsoNormal" style="text-align:center"
align="center"><span
style="font-family:"Verdana","sans-serif""
lang="ES">+55 86 3221-3062 (W), <o:p></o:p></span></p>
<p class="MsoNormal" style="text-align:center"
align="center"><span
style="font-family:"Verdana","sans-serif""
lang="ES">+55 86 3237-1075 (R). <o:p></o:p></span></p>
<p class="MsoNormal"><span
style="font-family:"Verdana","sans-serif""
lang="ES"><o:p> </o:p></span></p>
<p class="MsoNormal"><span
style="font-family:"Verdana","sans-serif""
lang="ES"><o:p> </o:p></span></p>
<p class="MsoNormal"><span
style="font-size:10.0pt;font-family:"Verdana","sans-serif""
lang="ES">Aviso: As informações contidas nesta
mensagem são CONFIDENCIAIS, protegidas pelo sigilo
legal, por direitos autorais e destinadas
exclusivamente à pessoa ou organização para a qual a
mensagem foi destinada.<o:p></o:p></span></p>
<p class="MsoNormal"><span
style="font-size:10.0pt;font-family:"Verdana","sans-serif""
lang="ES">Warning: This message is meant only for the
intended recipient of the transmission. It is
forbidden any unauthorized use, alteration,
reproduction and distribution. If you are not the
correct recipient, please notify us immediately by
return e-mail and delete this message from your
system.<o:p></o:p></span></p>
</div>
</div>
</div>
<table class="MsoNormalTable" border="0" cellpadding="0">
<tbody>
<tr>
<td style="background:white;padding:.75pt .75pt .75pt
.75pt">
<pre><span style="color:black">************************* AVISO LEGAL *************************<o:p></o:p></span></pre>
<pre><span style="color:black">Este mensaje electrónico está dirigido exclusivamente a sus destinatarios,<o:p></o:p></span></pre>
<pre><span style="color:black">pudiendo contener documentos anexos de carácter privado y confidencial.<o:p></o:p></span></pre>
<pre><span style="color:black">Si por error, ha recibido este mensaje y no se encuentra entre los<o:p></o:p></span></pre>
<pre><span style="color:black">destinatarios, por favor, no use, informe, distribuya, imprima o copie su<o:p></o:p></span></pre>
<pre><span style="color:black">contenido por ningún medio. Le rogamos lo comunique al remitente y borre<o:p></o:p></span></pre>
<pre><span style="color:black">completamente el mensaje y sus anexos. El Instituto de Salud Carlos III no<o:p></o:p></span></pre>
<pre><span style="color:black">asume ningún tipo de responsabilidad legal por el contenido de este mensaje<o:p></o:p></span></pre>
<pre><span style="color:black">cuando no responda a las funciones atribuidas al remitente del mismo por la<o:p></o:p></span></pre>
<pre><span style="color:black">normativa vigente.<o:p></o:p></span></pre>
</td>
</tr>
</tbody>
</table>
<p class="MsoNormal"><span lang="FR-CH"><o:p> </o:p></span></p>
<p class="MsoNormal"><span lang="FR-CH"><br>
<br>
--<br>
<i>This email was sent by icb.usp.br </i> ­­ <o:p></o:p></span></p>
</div>
<br>
<br>
--<br>
<i> This email was sent by icb.usp.br </i>
­­
<br>
<fieldset class="mimeAttachmentHeader"></fieldset>
<br>
<pre wrap="">_______________________________________________
Leish-l mailing list
<a class="moz-txt-link-abbreviated" href="mailto:Leish-l@lineu.icb.usp.br">Leish-l@lineu.icb.usp.br</a>
<a class="moz-txt-link-freetext" href="http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l">http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l</a>
--
This email was sent by icb.usp.br
</pre>
</blockquote>
<br>
<br>
<pre class="moz-signature" cols="72">--
Isabelle Thiery, PhD
Chargée de mission pour la logistique
Batiment 7 Le Pasteur, RDC droit, pièce 16
TEl : 01 45 68 83 43
<a class="moz-txt-link-abbreviated" href="mailto:Isabelle.thiery@pasteur.fr">Isabelle.thiery@pasteur.fr</a>
Institut Pasteur, 25 rue du Docteur Roux
75724 Paris Cedex 15, France
</pre>
</body>
</html>